Samardzija et al. observed the expression of OCT4 in ovarian CSC [31], and Di et al. found that peripheral blood T cells from ovarian cancer patient could be activated by OCT4 and became CD107a+ cells [32]. This evidence concerns the gene POU5F1 and ovarian carcinoma.